bedaquiline and Diabetes-Mellitus--Type-2

bedaquiline has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Reviews

1 review(s) available for bedaquiline and Diabetes-Mellitus--Type-2

Article	Year
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations. Drug design, development and therapy, 2016, Volume: 10 Antituberculosis (anti-TB) treatment may be affected by both diabetes and hypoglycemic agents in patients with these 2 comorbidities. However, data supporting this conclusion relate only to standard anti-TB therapies. Sirturo Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis	2016

Article

Year

Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.

Drug design, development and therapy, 2016, Volume: 10

Antituberculosis (anti-TB) treatment may be affected by both diabetes and hypoglycemic agents in patients with these 2 comorbidities. However, data supporting this conclusion relate only to standard anti-TB therapies. Sirturo

Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis

2016